Santen Pharmaceutical Co Stock Revenue
SNPHY Stock | USD 9.23 0.20 2.12% |
Santen Pharmaceutical Co fundamentals help investors to digest information that contributes to Santen Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Santen Pink Sheet. The fundamental analysis module provides a way to measure Santen Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Santen Pharmaceutical pink sheet.
Santen |
Santen Pharmaceutical Co Company Revenue Analysis
Santen Pharmaceutical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Santen Pharmaceutical Revenue | 266.26 B |
Most of Santen Pharmaceutical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Santen Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition |
Based on the latest financial disclosure, Santen Pharmaceutical Co reported 266.26 B of revenue. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The revenue for all United States stocks is significantly lower than that of the firm.
Santen Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Santen Pharmaceutical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Santen Pharmaceutical could also be used in its relative valuation, which is a method of valuing Santen Pharmaceutical by comparing valuation metrics of similar companies.Santen Pharmaceutical is currently under evaluation in revenue category among related companies.
Santen Fundamentals
Return On Equity | -0.0264 | |||
Return On Asset | -0.001 | |||
Profit Margin | (0.03) % | |||
Operating Margin | (0) % | |||
Current Valuation | 2.6 B | |||
Shares Outstanding | 388.22 M | |||
Shares Owned By Institutions | 0.02 % | |||
Price To Earning | 14.22 X | |||
Price To Book | 1.39 X | |||
Price To Sales | 0.01 X | |||
Revenue | 266.26 B | |||
Gross Profit | 156.59 B | |||
EBITDA | 53.91 B | |||
Net Income | 27.22 B | |||
Cash And Equivalents | 69.53 B | |||
Cash Per Share | 176.84 X | |||
Total Debt | 32.93 B | |||
Debt To Equity | 0.1 % | |||
Current Ratio | 2.48 X | |||
Book Value Per Share | 780.63 X | |||
Cash Flow From Operations | 46.04 B | |||
Earnings Per Share | 0.47 X | |||
Number Of Employees | 4.32 K | |||
Beta | 0.38 | |||
Market Capitalization | 2.94 B | |||
Total Asset | 459.98 B | |||
Retained Earnings | 230.22 B | |||
Working Capital | 106.3 B | |||
Current Asset | 156.63 B | |||
Current Liabilities | 50.32 B | |||
Annual Yield | 0.03 % | |||
Five Year Return | 1.68 % | |||
Net Asset | 459.98 B | |||
Last Dividend Paid | 16.0 |
About Santen Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Santen Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Santen Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Santen Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Santen Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Santen Pharmaceutical's short interest history, or implied volatility extrapolated from Santen Pharmaceutical options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Santen Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Santen Pharmaceutical information on this page should be used as a complementary analysis to other Santen Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Santen Pink Sheet analysis
When running Santen Pharmaceutical's price analysis, check to measure Santen Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santen Pharmaceutical is operating at the current time. Most of Santen Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Santen Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santen Pharmaceutical's price. Additionally, you may evaluate how the addition of Santen Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |